The Relationship Between Fluticasone Furoate Systemic Exposure and Cortisol Suppression
The Relationship Between Fluticasone Furoate Systemic Exposure and Cortisol Suppression
About this item
Full title
Author / Creator
Publisher
Cham: Springer International Publishing
Journal title
Language
English
Formats
Publication information
Publisher
Cham: Springer International Publishing
Subjects
More information
Scope and Contents
Contents
Introduction
The inhaled corticosteroid (ICS) fluticasone furoate is in development, in combination with the long-acting beta
2
-agonist vilanterol for the once-daily treatment of asthma and chronic obstructive pulmonary disease and as a monotherapy treatment for asthma. Corticosteroids, including ICSs, have the potential to induce dose-de...
Alternative Titles
Full title
The Relationship Between Fluticasone Furoate Systemic Exposure and Cortisol Suppression
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3779313
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3779313
Other Identifiers
ISSN
0312-5963,1179-1926
E-ISSN
1179-1926
DOI
10.1007/s40262-013-0078-1
